UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000042929
Receipt No. R000048852
Scientific Title Multicenter, single-arm prospective observational study
Date of disclosure of the study information 2021/02/28
Last modified on 2021/01/06 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Multicenter prospective cohort study to evaluate renal tubular function after switching from ETV to TAF
- Niigata University study group -
Acronym Multicenter prospective cohort study to evaluate renal tubular function after switching from ETV to TAF
- Niigata University study group -
Scientific Title Multicenter, single-arm prospective observational study
Scientific Title:Acronym Multicenter, single-arm prospective observational study
Region
Japan

Condition
Condition Patients with chronic hepatitis B in currently active treatment with ETV for more than 1year
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim of this study is to investigate changes in efficacy, safety, and tolerability after switching from ETV to TAF for
patients with chronic hepatitis B in active treatment.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Change in rate of virus suppression on 24 weeks after switching from ETV to TAF.
Key secondary outcomes Change in renal tubular function on 12 weeks after switching from ETV to TAF

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria Patients with chronic hepatitis B in currently active treatment with ETV for more than 1year
Key exclusion criteria Patients who have a history of hypersensitivity to TAF
Target sample size 50

Research contact person
Name of lead principal investigator
1st name Shuji
Middle name
Last name Terai
Organization Niigata University
Division name Division of gastroenterology
Zip code 951-8510
Address Niigata Japan
TEL 0252272207
Email hiroteruk@med.niigata-u.ac.jp

Public contact
Name of contact person
1st name Hiroteru
Middle name Kamimura
Last name Kamimura
Organization Niigata University
Division name Division of gastroenterology
Zip code 9518510
Address Niigata Japan
TEL 0252272207
Homepage URL
Email hiroteruk@med.niigata-u.ac.jp

Sponsor
Institute niigata university
Institute
Department

Funding Source
Organization niigata universuty
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization NiigataUniversity
Address Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata Japan
Tel 0252272207
Email hiroteruk@med.niigata-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 02 Month 28 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2020 Year 08 Month 01 Day
Date of IRB
2019 Year 10 Month 01 Day
Anticipated trial start date
2020 Year 08 Month 01 Day
Last follow-up date
2023 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information observation test

Management information
Registered date
2021 Year 01 Month 06 Day
Last modified on
2021 Year 01 Month 06 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048852